Clínic Barcelona
Clínic Barcelona
Research
June 12 2025
The "la Caixa" Foundation will allocate €150,000 to develop this project led by Eugenia Martínez Hernández, from the Pathogenesis of autoimmune neuro1
Treatment with trastuzumab deruxtecan, a combination of a targeted therapy with chemotherapy, increases progression-free survival of the disease and1
The finding may make it possible to take therapeutic approaches that will increase the success rate of cognitive-behavioral therapy. This is the ther1